Labour is accused of a 'disgraceful' silence as pharmacists say medicines shortage should be 'national priority' ...
A device for easing migraine pain, renovated veterans housing in Florida and an 100-year-old former Rosie the Riveter, Irene ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
Despite mixed results from its experimental schizophrenia treatment last month, MapLight Therapeutics is going all-in on the asset—at the expense of its preclinical programs. In its second-quarter ...
Centanafadine belongs to a new class of ADHD medicines. It’s the first to affect three brain chemicals: noradrenaline (known ...
A new pancreatic cancer drug nearly doubled survival in a major trial, giving patients and doctors new hope against a deadly disease.
HOT weather can make us all feel a bit ‘off’. But for millions of Brits, they are living with a health condition that makes them already vulnerable. Dr Lucy Hooper warns that, while ...
In this video, we explore two intriguing locations: an abandoned ghost town linked to a serial killer and a decaying mansion featuring a car graveyard that once belonged to a famous artist. The ...
Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...
Orexins are a pair of neurotransmitters—chemicals that carry messages between neurons. One of the main jobs of these particular neurotransmitters is to regulate wakefulness. And a new generation of ...
U.S. Department of Veterans Affairs sites begin prescribing ProlivRx for major depressive disorder and RelivionMG for migraine, expanding veterans' access to non-invasive, physician-supervised ...
Neurolief, a neuroscience-driven medical technology company developing brain neuromodulation therapies for mental health and neurological conditions, is bringing two prescription therapies to U.S.